| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SELECTA BIOSCIENCES INC | Director | Stock Option (Right to Buy) | 75,000 | $59,250 | $0.7900 | 02 Jan 2023 | Direct |
| EyePoint, Inc. | Director | Stock Option (Right to Buy) | 41,500 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EYPT | EyePoint, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:05 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 03 Jan 2025 | 1 | $0 | 4 | Director | 07 Jan 2025, 16:04 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 21 Aug 2024 | 1 | +$39,750 | 4 | Director | 21 Aug 2024, 16:01 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 05 Jan 2024 | 1 | $0 | 4 | Director | 09 Jan 2024, 20:53 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 20 Jun 2023 | 2 | $0 | 4 | Director | 22 Jun 2023, 09:19 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 09 Feb 2023 | 2 | $0 | 4 | Director | 13 Feb 2023, 16:04 |
| SELB | SELECTA BIOSCIENCES INC | 02 Jan 2023 | 1 | $0 | 4 | Director | 04 Jan 2023, 16:04 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 09 Feb 2022 | 4 | $0 | 4 | Director | 11 Feb 2022, 15:48 |
| SELB | SELECTA BIOSCIENCES INC | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 15:31 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 22 Jun 2021 | 2 | $0 | 4 | Director | 23 Jun 2021, 17:29 |